Monoallelic germline ATM mutation and organising pneumonia induced by radiation therapy to the breast.

Spectrom Rev 2005; 24: 661–700. 6 Lee TW, Brownlee KG, Conway SP, et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003; 2: 29–34. 7 Kumar S, Huang J, Abbassi-Ghadi N, et al. Selected ion flow tube mass spectrometry analysis of exhaled breath for volatile organic compound profiling of esophago-gastric cancer. Anal Chem 2013; 85: 6121–6128. 8 Sinha A, Krishnan V, Sethi T, et al. Metabolomic signatures in nuclear magnetic resonance spectra of exhaled breath condensate identify asthma. Eur Respir J 2012; 39: 500–502. 9 Montuschi P, Paris D, Montella S, et al. Nuclear magnetic resonance-based metabolomics discriminates primary ciliary dyskinesia from cystic fibrosis. Am J Respir Crit Care Med 2014; 190: 229–233. 10 Montuschi P, Paris D, Melck D, et al. NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax 2012; 67: 222–228. 11 de Carvalho Costa Cardinali L, Rocha GA, Rocha AM, et al. Evaluation of [C] urea breath test and Helicobacter pylori stool antigen test for diagnosis of H. pylori infection in children from a developing country. J Clin Microbiol 2003; 41: 3334–3335. 12 Prince BJ, Milligan DB, McEwan MJ. Application of selected ion flow tube mass spectrometry to real-time atmospheric monitoring. Rapid Commun Mass Spectrom 2010; 24: 1763–1769. 13 Montuschi P, Mores N, Trove A, et al. The electronic nose in respiratory medicine. Respiration 2013; 85: 72–84. 14 Goeminne PC, Vandendriessche T, Van Eldere J, et al. Detection of Pseudomonas aeruginosa in sputum headspace through volatile organic compound analysis. Respir Res 2012; 13: 87. 15 Ryall B, Davies JC, Wilson R, et al. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients. Eur Respir J 2008; 32: 740–747. 16 Smith D, Spanel P, Gilchrist FJ, et al. Hydrogen cyanide, a volatile biomarker of Pseudomonas aeruginosa infection. J Breath Res 2013; 7: 044001. 17 Dummer J, Storer M, Sturney S, et al. Quantification of hydrogen cyanide (HCN) in breath using selected ion flow tube mass spectrometry – HCN is not a biomarker of Pseudomonas in chronic suppurative lung disease. J Breath Res 2013; 7: 017105. 18 Chen W, Metsala M, Vaittinen O, et al. Hydrogen cyanide in the headspace of oral fluid and in mouth-exhaled breath. J Breath Res 2014; 8: 027108. 19 Robertson JM, Friedman EM, Rubin BK. Nasal and sinus disease in cystic fibrosis. Paediatr Respir Rev 2008; 9: 213–219.